EMA drug utilisation study of cyproterone-ethinylestradiol products

25/03/2013
02/04/2024
EU PAS number:
EUPAS3718
Study
Finalised
Study type

Study topic

Human medicinal product
DiseaseĀ /health condition

Study type

Non-interventional study

Scope of the study

Drug utilisation

Data collection methods

Secondary use of data
Study drug and medical condition

Study drug International non-proprietary name (INN) or common name

CYPROTERONE
ETHINYLESTRADIOL

Medical condition to be studied

Contraception
Population studied

Short description of the study population

Female patients receiving cyproterone/ethinylestradiol during 2002-2011.

Age groups

  • Adolescents (12 to < 18 years)
  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)

Estimated number of subjects

80000
Study design details

Main study objective

To study the drug utilisation of cyproterone/ethinylestradiol in Electronic Health Record databases from UK, France and Germany.

Data analysis plan

Descriptive analyses only